Nasdaq - Delayed Quote USD

T. Rowe Price Health Sciences (PRHSX)

93.40 -0.15 (-0.16%)
At close: 8:01 PM EDT

Top 9 Holdings (41.04% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 9.92%
UNH
UnitedHealth Group Incorporated 6.07%
ISRG
Intuitive Surgical, Inc. 4.13%
TMO
Thermo Fisher Scientific Inc. 4.04%
MRK
Merck & Co., Inc. 4.04%
SYK
Stryker Corporation 3.64%
ELV
Elevance Health, Inc. 3.55%
DHR
Danaher Corporation 2.96%
REGN
Regeneron Pharmaceuticals, Inc. 2.69%

Sector Weightings

SectorPRHSX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 0.13%
Stocks 90.19%
Bonds 0.00%
Others 9.49%
Preferred 0.09%
Convertible 0.10%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average PRHSX Category Average
Price/Earnings 0.03 24.55
Price/Book 0.18 5.28
Price/Sales 0.42 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 71,771.44 34,862.81
3 Year Earnings Growth 3.09 32.48

Bond Holdings

Average PRHSX Category Average
Maturity -- --
Duration 2.5 --
Credit Quality -- --

Performance & Risk

YTD Return 6.26%
5y Average Return 10.83%
Rank in Category (ytd) 33
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.76
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family T. Rowe Price
Net Assets 14.49B
YTD Return 2.58%
Yield 0.00%
Morningstar Rating
Inception Date Dec 29, 1995

Fund Summary

The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

Related Tickers